Poseida Therapeutics

Poseida Therapeutics

Multiple Sclerosis, (NCT07008378)
Sponsors:
Genentech, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Solid Tumors, (NCT05239143)
Sponsors:
Poseida Therapeutics 
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine